bioRxivImmunologyPreprint
Enhance Memory CD8+ T Cell Formation via Downregulation of Hematopoietic Progenitor Kinase 1 and Sustained Mitochondrial Fitness
Liuqing YangiD, Tantan Wang, Xiangna GuaniD, Chi HeiD, Hui ShiiD, Hong WuiD, Xuebin LiaoiD
Abstract
Memory CD8+ T cells are pivotal for long-term anti-tumor immunity due to their longevity and rapid response upon encountering tumor cells. Hematopoietic progenitor kinase 1 (HPK1), a member of the Ste20 family of kinases, restricts proximal T cell receptor (TCR) signaling and plays critical roles in T cell priming and activation. However, the impact of HPK1 on CD8+ T cell differentiation is not well understood. Here, we demonstrate that chimeric antigen receptor (CAR) T cells derived from patients lacking HPK1 exhibit a stronger memory phenotype. HPK1 deletion promotes the formation of precursor and central memory CD8+ T cells, resulting in superior and long-lasting antitumor activity in murine cancer models compared to WT mice. Additionally, HPK1 knockout induces metabolic reprogramming by enhancing oxidative phosphorylation (OXPHOS) and mitochondrial respiration complex activity. Mechanistically, HPK1 deletion downregulates mTOR signaling by reducing the phosphorylation of mTOR and S6. Increased mitophagy activity is observed in HPK1-depleted cells, with upregulation of key mitophagy regulators, including Pink1 and Bnip3l, maintaining mitochondrial fitness. Our study reveals that HPK1 regulates CD8+ T cell metabolic reprogramming, guiding cell differentiation and antitumor responses.
- organism: mouse
- assay: bulk RNA-seq
- assay: metabolomics
- research focus: cell type annotation
- research focus: metabolism & bioenergetics
- research focus: cancer & tumor microenvironment
- approach: genetic perturbation / CRISPR
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TCR/ITK signaling via mTOR tunes CD8+ T cell homeostatic proliferation, metabolism, and anti-tumor effector function
Weishan Huang, Junjie Luo, Avery August·bioRxiv·Jun 29, 2018
- DOK1 and DOK2 regulate CD8+ T cell signaling and memory formation without affecting tumor cell killing
V. Laletin, P.-L. Bernard, … J. Nunes·bioRxiv·Dec 17, 2021
- Phospho-enol pyruvate carboxykinase inhibition limits inflammatory T cell activation
Rebecca J. Brownlie, Helen Carrasco Hope, … Robert J. Salmond·bioRxiv·Sep 9, 2025
- Tumor-derived mitochondria enhance CD8+ T cell cytotoxicity through SPHK2-dependent S1P signaling
Chuanfang Chen, Xiunan Wang, … Shih‐Chin Cheng·bioRxiv·May 17, 2026
- Metabolic Reprogramming Driven by Ant2 -Targeting Augments T-Cell Function and Anti-Tumor Immunity
Omri Yosef, Leonor Cohen‐Daniel, … Michael Berger·Nature CommunicationsPeer-reviewed·May 8, 2025
- HIF-1α-mediated mitochondrial-glycolytic reprogramming controls the transition of precursor to terminally exhausted T cells